1.Impact of sperm source and parameters on the outcome of intracytoplasmic sperm injection.
Qiao TAN ; Nenghui LIU ; Yanping LI ; Dong'e LIU ; Xianhua CHEN
Journal of Central South University(Medical Sciences) 2011;36(2):149-153
OBJECTIVE:
To evaluate the impact of sperm source and sperm parameters on the outcome of intracytoplasmic sperm injection (ICSI).
METHODS:
This retrospective study included 433 ICSI cycles from June 2005 to December 2008 in Reproductive Medical Center of Xiangya Hospital. The patients were divided into 2 major groups according to the source of spermatozoa used for ICSI: ejaculated (group A, n=336) and epididymal (group B, n=97). Group A was divided into 3 subgroups according to the sperm parameters: normal (Group A1, n=95), single parameter defect (Group A2, n=119), and multiple parameter defect (Group A3, n=122).
RESULTS:
The basic characteristics among the 4 groups had no statistic difference (P>0.05), and the difference in the fertilization rate, normal fertilization rate, cleaving embryo rate,good quality embryo rate, implanted rate, clinical pregnancy rate, and early abortion rate among the 4 groups were not significant (P>0.05).
CONCLUSION
The outcome is similar no matter whether the spermatozoa is from ejaculated sperm or epididymis. ICSI can treat male infertility of various factors, and the outcome is the same with one or multiple sperm parameter abnormality. ICSI with epididymal spermatozoa through percutaneous epididymal sperm aspiration is effective for infertility due to obstructive azoospermia.
Adult
;
Epididymis
;
cytology
;
physiopathology
;
Female
;
Fertilization
;
Humans
;
Infertility, Male
;
therapy
;
Male
;
Pregnancy
;
Pregnancy Outcome
;
Retrospective Studies
;
Sperm Injections, Intracytoplasmic
;
methods
;
Sperm Motility
;
physiology
;
Sperm Retrieval
;
Spermatozoa
;
physiology
2.New Chinese Medicine Methodology of One Research Path——"from Experiment to Clinical Verification" on Key Technology of Translational Medicine
Hong ZHANG ; Jialin DU ; Ying ZHANG ; Maoxin LIANG ; Yv GAN ; Guanghan WANG ; Min QIAO ; Guixin ZOU ; Shaojie XIANG ; Xianhua LI ; Xianmin YOU ; Yinglan FAN ; Xiaolin WU ; Lei ZHAO ; Guoxin LI
World Science and Technology-Modernization of Traditional Chinese Medicine 2017;19(4):542-548
Translational medicine means that to establish a bridge between fundamental research and clinical medicine through bidirectional translation path in order to promote the translation and application from fundamental research to clinical medicine.The purpose of traditional Chinese medicine (TCM) translational model is to collate and build one multidimensional TCM translational model,rationality carry out the research on TCM translation.Three paths have been confirmed,where are from literature research to clinical verification,from clinical application to clinical verification,and from experiment to clinical verification.In this research,methodology of one path mcntioned above could be established,which is the key technology of translational medicine.Take constipation,insomnia,and post-flu cough as target diseases to investigate the herbal compounds which could be qualified for clinical application based on preliminary work.This research not only provided clinical data to TCM translation,but also established one methodology of TCM translation path--"from experiment to clinical verification".
3.Shikonin Inhibits Inflammation of Psoriasis Cell Model by Regulating cGAS/STING Signaling Pathway
Chong LYU ; Xianhua QIAO ; Juanjuan GAO ; Fei TIAN ; Kuilong ZHOU ; Chengcheng WANG ; Jiepeng WANG
Chinese Journal of Experimental Traditional Medical Formulae 2024;30(24):114-120
ObjectiveTo investigate the effect of shikosin (SHI) on psoriasis (PSO) and explore the underlying mechanism via the cyclic guanosine monophosphate-adenosine monophosphate synthase (cGAS)/stimulator of interferon genes (STING) signaling pathway. MethodHaCaT cells were classified into normal culture(Control), a mixture of five proinflammatory cytokines(M5), low-, medium-, and high-dose SHI (L-SHI, M-SHI, and H-SHI, respectively), and SHI+ADU-S100 groups. The cells in the M5 group were stimulated with 10 μg·L-1 interleukin (IL)-1α, IL-17, IL-22, tumor necrosis factor (TNF)-α, and oncostatin M (OSM) for 48 h. The cells in the L-SHI, M-SHI, and H-SHI groups were treated with 0.1, 1, 10 μmol·L-1 SHI, respectively, on the basis of the treatment in the M5 group. The cells in the SHI+ADU-S100 group were treated with 10 μmol·L-1 STING activator ADU-S100 on the basis of the treatment in the H-SHI group. The methyl thiazolyl tetrazolium (MTT) assay and colony formation assay were employed to examine the effect of SHI on the proliferation of HaCaT cells. The wound healing assay was employed to examine the effect of SHI on the migration of HaCaT cells. Flow cytometry was employed to detect the effect of SHI on the apoptosis of HaCaT cells. Enzyme-linked immunosorbent assay was employed to measure the levels of IL-1β, IL-6, IL-15, IL-23, and interferon-γ (IFN-γ) in HaCaT cells. Western blot was employed to determine the protein levels of cGAS and STING in HaCaT cells. ResultCompared with Control group, the M5 group showed decreased survival rate, colony formation, and would healing rate of HaCaT cells, increased apoptosis rate, elevated levels of IL-1β, IL-6, IL-15, IL-23, and IFN-γ, and up-regulated protein levels of cGAS and STING (P<0.01). Compared with the M5 group, the L-SHI, M-SHI, and H-SHI groups showed increased survival rate, cell colony formation, and wound healing rate, decreased apoptosis rate, lowered levels of IL-1β, IL-6, IL-15, IL-23, and IFN-γ, and down-regulated protein levels of cGAS and STING (P<0.01). Compared with the H-SHI group, the SHI+ADU-S100 group showed decreased survival rate, cell colony formation, and wound healing rate, increased apoptosis rate, risen levels of IL-1β, IL-6, IL-15, IL-23, and IFN-γ, and up-regulated protein levels of cGAS and STING (P<0.01). ConclusionSHI can inhibit the inflammation in the cell model of PSO by inhibiting the cGAS/STING signaling pathway.